Takeda clears key hurdle as investors back $59 billion Shire deal
2018-12-5 05:48 pm
Takeda Pharmaceutical has won shareholder approval for its $59 billion takeover of London-listed Shire , creating a global powerhouse that has a stronger drugs pipeline but is also saddled with massive debt.
Read The Rest at
Russia's Gazprom Neft sticking with plan to...
Unilever's Polman calls for trust in farewell...
You May Also Like
MLB Rumors: Brock Holt agrees to deal with Brewers
A's Liam Hendriks helps fire victims back home...
Delta says it will invest $1 billion to cut...
Quarantine ruling: Russia sends woman back...
Jeff Bezos commits $10 billion to fight climate...
United and American push back expected return...
Berlin / Germany
Sydney / Australia
All Rights Reserved
Powered By RSS-Script Light Version